| 25731686 | Targeting the spindle assembly checkpoint for breast cancer treatment. | Curr Cancer Drug Targets | 2015 | Marques S | - |
| 28751540 | TTK Inhibitors as a Targeted Therapy for CTNNB1 (β-catenin) Mutant Cancers. | Mol Cancer Ther | 2017 Nov | Zaman GJR | doi: 10.1158/1535-7163.MCT-17-0342 |
| 26398286 | Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility. | PLoS One | 2015 Sep 23 | Martinez R | doi: 10.1371/journal.pone.0138616 |
| 17784873 | Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. | Cancer Sci | 2007 Nov | Suda T | - |
| 27383047 | Mps1 kinase regulates tumor cell viability via its novel role in mitochondria. | Cell Death Dis | 2016 Jul 7 | Zhang X | doi: 10.1038/cddis.2016.193. |
| 26637805 | Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition. | Oncotarget | 2016 Jan 5 | Jema?? M | doi: 10.18632/oncotarget.6432. |
| 26068855 | CELL DIVISION CYCLE. Competition between MPS1 and microtubules at kinetochores regulates spindle checkpoint signaling. | Science | 2015 Jun 12 | Hiruma Y | doi: 10.1126/science.aaa4055 |
| 27522003 | HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells. | Biomed Pharmacother | 2016 Oct | Chen S | doi: 10.1016/j.biopha.2016.08.004 |
| 21402910 | High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. | Proc Natl Acad Sci U S A | 2011 Mar 29 | Daniel J | doi: 10.1073/pnas.1007645108 |
| 21163887 | High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint. | Carcinogenesis | 2011 Mar | Niittymki I | doi: 10.1093/carcin/bgq272 |
| 16864798 | MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability. | Proc Natl Acad Sci U S A | 2006 Aug 1 | Leng M | - |
| 25137017 | Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells. | Br J Cancer | 2014 Oct 28 | Kaistha BP | doi: 10.1038/bjc.2014.460 |
| 24462521 | TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers. | Mol Oncol | 2014 May | Gyrffy B | doi: 10.1016/j.molonc.2013.12.018 |
| 23700430 | TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer. | PLoS One | 2013 May 20 | Maire V | doi: 10.1371/journal.pone.0063712 |
| 28380042 | Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability. | PLoS One | 2017 Apr 5 | Stratford JK | doi: 10.1371/journal.pone.0174863 |
| 27833085 | TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. | Oncotarget | 2016 Dec 6 | Xu Q | doi: 10.18632/oncotarget.13245. |
| 28883705 | Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer. | World J Gastroenterol | 2017 Aug 21 | Xie Y | doi: 10.3748/wjg.v23.i31.5787. |
| 27618777 | Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer. | Sci Rep | 2016 Sep 13 | Miao R | doi: 10.1038/srep33121. |
